Pemphigus treatment in Japan.

[1]  H. Shimizu,et al.  A randomized double-blind trial of intravenous immunoglobulin for pemphigus. , 2009, Journal of the American Academy of Dermatology.

[2]  H. Shimizu,et al.  Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. , 2008, Journal of the American Academy of Dermatology.

[3]  R. Gniadecki,et al.  Two courses of rituximab (anti‐CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris , 2008, International journal of dermatology.